Emerging Market Trends For Drug Delivery Devices
By Aashi Mishra, Research Nester
Market size for drug delivery devices is estimated to top $540 billion by 2035. This article shares research on market segmentation by routes of administration, product types (inhalers, smart pills, drug-eluting stents), regions, and more.
Evolution Of Novel Polymers To Overcome Limits In Sustained Drug Delivery
Article | DSM Biomedical
Degradable polymers have evolved from aliphatic polyesters to nitrogen-containing biomaterials. Here is a brief history of the development of PEA polymers.
Prefilled Syringes Market Trends: Improving Patient Experience
Q&A | PCI Pharma Services
Learn how sterile injectable devices are providing safer and more convenient self-injection delivery, leading to positive patient experiences, better therapy adherence, and improved outcomes.
Driving Sustainability In Spray Drying Through Enabling Technologies
Article | By David Lyon, Ph.D., Molly Adam, and John Baumann, Lonza
By transitioning to alternative solvents or leveraging process aids, the challenges associated with the use of these chemicals can be addressed, helping create a sustainable, greener footprint.
Transitioning From A Vial To PFS Or Cartridge In An Auto-Injector Device
Article | By Jo Anne Jacobs, INCOG BioPharma Services
Explore how to approach the transition of migrating from a vial to a syringe or cartridge, the necessary compatibility testing, and the stresses on the bulk product during formulation and filling.
Combining Gene Therapies, Carrier Systems, And Medical Devices
Article | By Stefanie Johns, Ph.D., Kymanox Corporation
Drug delivery is one of the most significant obstacles to advancing gene therapies. Examine the opportunities for success in combining novel medical devices to improve delivery of gene therapies.
Innovative Softgel Technologies To Deliver Poorly Soluble Molecules
e-book | Catalent
Learn how to expedite the development pathway for early-phase compounds and how lipid-based formulations provide an innovative approach to enhance bioavailability for challenging molecules.
Collaborating With A CMO To Bring Your Sterile Injectable Product To Market
White Paper | Simtra BioPharma Solutions
Review considerations for collaborating with a fill/finish CMO, including CMO selection, request for proposal (RFP) delivery, proposal review, and project award.
Choosing A Formulation And Process Approach To OCR Products
White Paper | By Richard Sidwell, Ph.D., Societal CDMO
Do you want to develop an oral controlled release (OCR) product? Understand the options and their ramifications as the first step toward devising a plan.
Excel IV: An Evolving Market Affirms The Value Of An Established Offering
B. Braun OEM Division
Enabling The Delivery Of Complex Biologics With Ergonomic Solutions
BD Medical - Pharmaceutical Systems
Vertiva On-Body Delivery System